Gesamtlänge aller Episoden: 11 days 13 hours 57 minutes
Perry Elliott, MD, FRCP - What’s New and What’s Next? Expanding Our Understanding of HCM in 2023
Edward B. Garon, MD, MS - Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet Needs in NSCLC Without Actionable Mutations
Claus Vogelmeier, MD - Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD
Andreea Ciudin, MD, PhD - Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on the Modernisation of Obesity Care
Perry Elliott, MD, FRCP - Continuing Our Conversation in HCM: Compelling Questions and Evolving Considerations
Ronald F. van Vollenhoven, MD, PhD - Key Updates on the Treatment Paradigm for Systemic Lupus Erythematosus
Angela Lamarca, MD, PhD, MSc - Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplinary Care, Molecular Testing, and Targeted Treatment
Andreas Kremer, MD, PhD, MHBA - Initiating the Conversation on Itch: Modelling Best Practices in Patient-Centred Care for Cholestatic Pruritus in PBC
Walter Chow, BScPhm, MD - Better Outcomes for Your Patients Living With Obesity: Practical Management Strategies for Primary Care
Martin van Hagen, MD, PhD - Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-Integrated Care